Literature DB >> 26630949

Developing and implementing a complex Complementary and Alternative (CAM) nursing intervention for breast and gynecologic cancer patients undergoing chemotherapy--report from the CONGO (complementary nursing in gynecologic oncology) study.

Nadja Klafke1, Cornelia Mahler2, Cornelia von Hagens3, Gisela Blaser4, Martina Bentner2, Stefanie Joos5.   

Abstract

PURPOSE/
OBJECTIVES: The purpose of this study was to develop a complex nursing intervention including complementary and alternative medicine (CAM) for breast and gynecologic cancer patients during chemotherapy to improve quality of life.
METHODS: Data sources Theoretical framework and concepts, practical nursing knowledge, and evidence-based studies were compiled in interprofessional meetings. Data synthesis The final complex intervention consists of three autonomous, but interacting components: (1) CAM nursing package, (2) resource-oriented counseling, and (3) evidence-based information material on CAM. CAM interventions include acupressure, aromatherapy, compress, and massage, targeting 14 clinically relevant symptoms during chemotherapy. Participants receive these interventions during chemotherapy with instructions for self care. During a counseling interview, the patient's needs and preferences are assessed by trained nurses. Furthermore, participants are equipped with evidence-based information material (booklet and DVD). Prior to study start, nurses attended training modules for administering CAM therapies and for communicating and counseling within the salutogenic approach.
CONCLUSIONS: It was possible to design a multimodal CAM nursing intervention based on a theoretical concept, evidence-based studies, and practical nursing experience targeting the prevention or relief of side-effects women suffer during chemotherapy. The systematic analysis of the CONGO study will contribute to evidence-based CAM nursing care within supportive cancer care. IMPLICATIONS FOR INTEGRATIVE CANCER CARE: Oncology nurses play an important role in supportive CAM care of breast and gynecologic cancer patients in daily clinical practice. Within oncology outpatient services, the implementation of evidence-based CAM nursing interventions and counseling may contribute to understand the impact of nursing on patient quality of life and symptom relief. This can lead to a new understanding of the nurse's professional role.

Entities:  

Keywords:  Breast and gynecologic cancer; Complementary and alternative medicine; Integrative cancer care; Nursing counseling; Nursing intervention; Quality of life; Salutogenesis; Self care; Supportive cancer care

Mesh:

Year:  2015        PMID: 26630949     DOI: 10.1007/s00520-015-3038-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  37 in total

1.  The varied contribution of significant others to Complementary and Alternative Medicine (CAM) uptake by men with cancer: a qualitative analysis.

Authors:  Nadja Klafke; Jaklin A Eliott; Ian N Olver; Gary A Wittert
Journal:  Eur J Oncol Nurs       Date:  2014-03-26       Impact factor: 2.398

Review 2.  Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting.

Authors:  Janelle M Tipton; Roxanne W McDaniel; Laurel Barbour; Mary Pat Johnston; Marilyn Kayne; Patricia LeRoy; Marita L Ripple
Journal:  Clin J Oncol Nurs       Date:  2007-02       Impact factor: 1.027

Review 3.  How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.

Authors:  Markus Horneber; Gerd Bueschel; Gabriele Dennert; Danuta Less; Erik Ritter; Marcel Zwahlen
Journal:  Integr Cancer Ther       Date:  2011-10-21       Impact factor: 3.279

4.  Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

Authors:  Gary E Deng; Moshe Frenkel; Lorenzo Cohen; Barrie R Cassileth; Donald I Abrams; Jillian L Capodice; Kerry S Courneya; Trish Dryden; Suzanne Hanser; Nagi Kumar; Dan Labriola; Diane W Wardell; Stephen Sagar
Journal:  J Soc Integr Oncol       Date:  2009

Review 5.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Ethan Basch; Ann Alexis Prestrud; Paul J Hesketh; Mark G Kris; Petra C Feyer; Mark R Somerfield; Maurice Chesney; Rebecca Anne Clark-Snow; Anne Marie Flaherty; Barbara Freundlich; Gary Morrow; Kamakshi V Rao; Rowena N Schwartz; Gary H Lyman
Journal:  J Clin Oncol       Date:  2011-09-26       Impact factor: 44.544

6.  Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.

Authors:  Alexander Molassiotis; Matti Aapro; Mario Dicato; Pere Gascon; Sylvia A Novoa; Nicolas Isambert; Thomas A Burke; Anna Gu; Fausto Roila
Journal:  J Pain Symptom Manage       Date:  2013-09-24       Impact factor: 3.612

7.  The effect of symptom clusters on functional status and quality of life in women with breast cancer.

Authors:  Marylin J Dodd; Maria H Cho; Bruce A Cooper; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2009-11-07       Impact factor: 2.398

8.  Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care?

Authors:  Carolyn Lefkowits; Michael W Rabow; Alexander E Sherman; Tuyen K Kiet; Rachel Ruskin; John K Chan; Lee-may Chen
Journal:  Gynecol Oncol       Date:  2014-01-25       Impact factor: 5.482

9.  Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

Review 10.  Quality of life and psychosocial adjustment in gynecologic cancer survivors.

Authors:  Timothy Pearman
Journal:  Health Qual Life Outcomes       Date:  2003-08-20       Impact factor: 3.186

View more
  6 in total

1.  Protocol for the process evaluation of a counselling intervention designed to educate cancer patients on complementary and integrative health care and promote interprofessional collaboration in this area (the CCC-Integrativ study).

Authors:  Jasmin Bossert; Cornelia Mahler; Ursula Boltenhagen; Anna Kaltenbach; Daniela Froehlich; Joachim Szecsenyi; Michel Wensing; Stefanie Joos; Nadja Klafke
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

Review 2.  The power of touch: external applications from whole medical systems in the care of cancer patients (literature review).

Authors:  Inga Mühlenpfordt; Wiebke Stritter; Mathias Bertram; Eran Ben-Arye; Georg Seifert
Journal:  Support Care Cancer       Date:  2019-11-29       Impact factor: 3.603

3.  Effects of relaxation on self-esteem of patients with cancer: a randomized clinical trial.

Authors:  Mehdi Harorani; Masoomeh Noruzi Zamenjani; Mohamad Golitaleb; Fahimeh Davodabady; Sima Zahedi; Ali Jadidi; Masoud Rezaei
Journal:  Support Care Cancer       Date:  2019-08-16       Impact factor: 3.603

4.  The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.

Authors:  Nadja Klafke; Cornelia Mahler; Cornelia von Hagens; Lorenz Uhlmann; Martina Bentner; Andreas Schneeweiss; Andreas Mueller; Joachim Szecsenyi; Stefanie Joos
Journal:  Cancer Med       Date:  2019-05-21       Impact factor: 4.452

5.  Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.575

6.  Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.

Authors:  Mette Stie; Charlotte Delmar; Birgitte Nørgaard; Lars Henrik Jensen
Journal:  BMJ Open       Date:  2022-04-25       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.